If you are not happy with the results, please do another search

JSA advises Kotak Securities Limited on Timex Group Offer for Sale

JSA Advocates and Solicitors advised Kotak Securities Limited on the offer for sale of equity shares of Timex Group India by its promoter, Timex Group Luxury Watches B.V., Netherlands, through the stock exchange mechanism, valued at USD 33.10 million.

JSA’s team was led by Arka Mookerjee (Lead Partner), along with the Equity Capital Markets team, including Pracheta Bhattacharya (Partner) and Kairav Parikh (Principal Associate).

JSA advises SBI Capital Markets, Ambit Private and IIFL Capital Services on Rayzon Solar Limited’s Proposed IPO

JSA is advising SBI Capital Markets Limited, Ambit Private Limited, and IIFL Capital Services Limited (formerly known as IIFL Securities Limited) in connection with the proposed initial public offering of equity shares of Rayzon Solar Limited(“IPO”), comprising a fresh issue aggregating up to ₹15,000 million. Rayzon Solar Limited has filed its draft red herring prospectus with the Securities and Exchange Board of India (SEBI) and the stock exchanges.

The transaction is being led by Arka Mookerjee (Partner), with support from JSA’s Equity Capital Markets team: Siddhartha Desai (Partner), Arjun Rastogi (Principal Associate), Govind Roy(Senior Associate), and Prateek Khandelwal, Aditya Shendye, Ayushi Pandit, and Anvita Sinha (Associates).

JSA successfully represents Mr. Rajesh Mokashi, former MD of CARE Ratings, before SAT, resulting in SEBI’s Order being set aside and costs being imposed on SEBI

JSA has successfully represented Mr. Rajesh Mokashi, former Managing Director of CARE Ratings Limited, in proceedings before the Hon’ble Securities Appellate Tribunal, Mumbai (“SAT”), challenging an order dated April 20, 2023 (“Impugned Order”) passed by the Whole Time Member of the Securities and Exchange Board of India (“SEBI”).

The Impugned Order had restrained Mr. Mokashi from associating with any SEBI-registered intermediary for two years, based on allegations of interference in the rating process relating to DHFL.

By its final order dated June 27, 2025, the SAT, comprising Hon’ble Justice P.S. Dinesh Kumar (Presiding Officer) and Hon’ble Dr. Dheeraj Bhatnagar (Technical Member), allowed Mr. Mokashi’s appeal and set aside the Impugned Order. The SAT imposed a cost of ₹5 lakh on SEBI, observing that:

  • Justice B.N. Srikrishna’s independent report had exonerated Mr. Mokashi of all charges, finding no evidence of interference with the rating process.
  • SEBI erred in misconstruing the findings of the Srikrishna report.
  • The evidence, including cross-examination of key witnesses, did not support SEBI’s conclusion.
  • SEBI’s actions were reprehensible and caused colossal loss of judicial time and resources, irreparable damage to Mr. Mokashi’s reputation, and significant financial loss and loss of opportunity.

 

The matter was led by Pulkit Sukhramani (Partner) with support from JSA’s Disputes team comprising Anshuman Sugla (Senior Associate), Samreen Fatima (Senior Associate), and Juan D’souza (Associate).

Rise of Indian Private Credit

Welcome to the special episode of the Mint Podcast, presented by Mint in collaboration with JSA Advocates & Solicitors, which is now live.

In this episode, hosted by Neil Borate, our partners Tirthankar Datta and Divyanshu Pandey delve into the dynamic rise of private credit within India’s financial landscape. They provide an in-depth analysis of the key growth drivers propelling this sector forward, examine current investor trends that are shaping its trajectory, and discuss the evolving regulatory environment that is impacting its development.

Initial Public Offering of Oswal Pumps Limited

JSA Advocates and Solicitors advised the book running lead managers, namely, IIFL Capital Services Limited (formerly known as IIFL Securities Limited), Axis Capital Limited, CLSA India Private Limited, JM Financial Limited, and Nuvama Wealth Management Limited, on Oswal Pumps Limited’s initial public offering of approximately ₹1,694 crore (which included the secondary sale of approximately ₹300 crore by the Promoter Selling Shareholder). The Prospectus was filed on June 17, 2025 further to which the equity shares commenced trading on the stock exchanges on June 20, 2025.

JSA’s team was led by Arka Mookerjee (Lead Partner), along with support from Pracheta Bhattacharya (Partner) and Anshu Bansal (Partner), and Ananth Balaji (Principal Associate), Govind Roy (Senior Associate), Ayushi Pandit (Associate), Aditi Khandal (Associate), Ritu R Jaiswal (Associate), Vaishnavi Kokkonda (Associate)

JSA represented Biocon Limited in raising ₹4,500 crore through a Qualified Institutions Placement

JSA Advocates and Solicitors represented Biocon Limited with its Qualified Institutions Placement (“QIP”) of equity shares amounting to ₹4,500 crore. Kotak Mahindra Capital Company Limited, BofA Securities India Limited, and Goldman Sachs (India) Securities Private Limited acted as Book Running Lead Managers to the QIP.

JSA’s team led by Madhurima Mukherjee Saha (Lead Partner), along with support from Equity Capital Markets team, including Sagar Batra (Partner), and Bhavini Mohan (Senior Associate), Aryaman Singh (Associate), Nidhi Prakriti (Associate), Rachit Munjal (Associate), advised the Biocon Limited.